Diagnostic clinical application of two-color fluorescence in situ hybridization that detects chromosome 1 and 17 alterations to direct touch smear and liquid-based thin-layer cytologic preparations of endometrial cancers

This publication has 30 references indexed in Scilit:

• Genetic Imbalances in Precursor Lesions of Endometrial Cancer Detected by Comparative Genomic Hybridization
  The American Journal of Pathology, 2000
• HER-2/neu gene amplification in stages I-IV breast cancer detected by fluorescent in situ hybridization
  Genetics in Medicine, 1999
• The accuracy of endometrial cytology in the diagnosis of endometrial adenocarcinoma
  Cytopathology, 1998
• Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening
  Obstetrics & Gynecology, 1997
• Detection of malignancy in endometrium by brush sampling in 1042 symptomatic patients
  International Journal of Gynecologic Cancer, 1995
• High-resolution cytogenetic mapping of the short arm of chromosome 1 with newly isolated 411 cosmid markers by fluorescence in situ hybridization: the precise order of 18 markers on 1p36.1 on prophase chromosomes and “stretched” DNAs
  Genomics, 1995
• Detailed analysis of loss of heterozygosity on chromosome band 17p13 in breast carcinoma on the basis of a high‐resolution physical map with 29 markers
  Genes, Chromosomes and Cancer, 1994
• High-Resolution Cytogenetic Mapping of 342 New Cosmid Markers Including 43 RFLP Markers on Human Chromosome 17 by Fluorescence in Situ Hybridization
  Genomics, 1993
• p53, guardian of the genome
  Nature, 1992
• Marker chromosomes of the long arm of chromosome 1 in endometrial carcinoma
  Cancer Genetics and Cytogenetics, 1985